Evaluation of carbapenem inactivation method-based phenotypic assays for the detection of GES-type carbapenemases in Enterobacterales, Pseudomonas aeruginosa , and Acinetobacter baumannii
Journal of Clinical Microbiology · 09.09.2026 · 64 (9)
DOI: 10.1128/jcm.00737-26 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 09.09.2026. Verfasst von Samuel García-García und 20 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander, Spain. Hauptthemen laut MEDLINE: beta-Lactamases, Acinetobacter baumannii, Pseudomonas aeruginosa, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIBERES-Centro de Investigación Biomédica en Red. Enfermedades Respiratorias, CIBER -Consorcio Centro de Investigación Biomédica en Red, Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA).
Abstract (Originalsprache)
Detection of GES-type carbapenemases remains challenging because of their low prevalence and frequently weak hydrolytic activity against carbapenems. Carbapenem inactivation method (CIM)-based assays are widely used as phenotypic screening tools for carbapenemase detection; however, their performance in large collections of GES producers has not been systematically evaluated. We assessed the performance of CIM, modified CIM (mCIM), and CIM-Tris in a diverse collection of GES-producing clinical isolates, including 110 Enterobacterales and 108 Pseudomonas aeruginosa, recovered from Spanish hospitals (2010–2024), and 10 Acinetobacter baumannii isolates, mostly obtained from a hospital in Egypt. Whole-genome sequencing was carried out for species confirmation and resistome analysis. Meropenem MICs were determined by broth microdilution. Overall, 92.1% of isolates were GES-carbapenemase producers (CP), whereas 7.9% expressed GES-type extended-spectrum β-lactamases (ESBLs). In Enterobacterales (predominantly carrying bla GES-6 ), mCIM improved sensitivity compared with CIM (63.6% vs 40.0%), although many isolates remained undetected due to low meropenem MICs (MIC 50 , 0.5 µg/mL). In CP- P. aeruginosa (mainly bla GES-5 ), CIM, mCIM, and CIM-Tris showed sensitivities of 89.1%, 94.6%, and 100%, respectively; however, CIM-Tris yielded false-positive results in 50% of non-CP isolates (mostly bla GES-1 producers). Meropenem MICs in P. aeruginosa were higher (MIC 50 , >32 µg/mL). In A. baumannii , CIM-Tris improved sensitivity compared with CIM (100% vs 25.0%). These findings indicate that CIM-based methods can detect GES-type carbapenemases, but performance varies according to bacterial species and GES variant, and reduced specificity may occur in isolates producing GES-type ESBLs. Complementary molecular testing may therefore be necessary to ensure accurate detection of GES-type carbapenemases in routine clinical laboratories. IMPORTANCE GES-type carbapenemases represent an important but underrecognized diagnostic challenge due to their low global prevalence, heterogeneous hydrolytic activity, and the limited performance data available for routine phenotypic detection methods. Although CIM-based assays are widely implemented in clinical microbiology laboratories for carbapenemase screening, their performance against GES-producing organisms has not been comprehensively evaluated across different bacterial genera and GES variants. In this study, we evaluated the performance of CIM, modified CIM (mCIM), and CIM-Tris in a large multicenter collection of well-characterized GES-producing clinical isolates, including Enterobacterales, Pseudomonas aeruginosa , and Acinetobacter baumannii . Our findings demonstrate substantial variability in assay performance according to bacterial species and GES variant. Notably, mCIM improved sensitivity among Enterobacterales with low meropenem MICs, whereas CIM-Tris achieved excellent sensitivity in P. aeruginosa and A. baumannii but at the expense of reduced specificity in isolates producing GES-type ESBLs. To the best of our knowledge, this is the first study directly comparing multiple CIM-based approaches in such a large and taxonomically diverse collection of GES-producing isolates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander, Spain.
- CIBER de Enfermedades Infecciosas-CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
- Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain.
- Servicio de Microbiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (Imas 12), Madrid, Spain.
- Servicio de Microbiología, Hospital Universitario La Princesa, Madrid, Spain.
- Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, Spain.
ORCID-Profile: Samuel García-García, Jorge Rodríguez-Grande, María Siller-Ruíz, Esther Viedma, Marta Hernández-García, Javier Fernández-Domínguez, Patricia Ruiz-Garbajosa, Alain Ocampo-Sosa, Sergio García-Fernández
Förderung
- CIBERES-Centro de Investigación Biomédica en Red. Enfermedades Respiratorias
- CIBER -Consorcio Centro de Investigación Biomédica en Red
- Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA)
Zitieren
APA
García-García, S., Rodríguez-Grande, J., Siller-Ruíz, M., Arjona-Torres, C., Viedma, E., Díez-Aguilar, M., Hernández-García, M., Fernández-Domínguez, J., Cercenado, E., Lázaro-Perona, F., Oteo-Iglesias, J., Ruiz-Garbajosa, P., Cantón, R., Valcárcel-Fraile, N., Gallego, L., Roiz-Mesones, M. P., Calvo-Montes, J., Martínez-Martínez, L., Ocampo-Sosa, A., …, & GEMARA-GESPABE Study Group (2026). Evaluation of carbapenem inactivation method-based phenotypic assays for the detection of GES-type carbapenemases in Enterobacterales, Pseudomonas aeruginosa , and Acinetobacter baumannii. Journal of Clinical Microbiology, 64(9). https://doi.org/10.1128/jcm.00737-26
Vancouver
García-García S, Rodríguez-Grande J, Siller-Ruíz M, Arjona-Torres C, Viedma E, Díez-Aguilar M, et al. Evaluation of carbapenem inactivation method-based phenotypic assays for the detection of GES-type carbapenemases in Enterobacterales, Pseudomonas aeruginosa , and Acinetobacter baumannii. Journal of Clinical Microbiology. 2026;64(9). doi:10.1128/jcm.00737-26
BibTeX
@article{GarcaGarca2026,
author = {García-García, Samuel and Rodríguez-Grande, Jorge and Siller-Ruíz, María and Arjona-Torres, Cristina and Viedma, Esther and Díez-Aguilar, María and Hernández-García, Marta and Fernández-Domínguez, Javier and Cercenado, Emilia and Lázaro-Perona, Fernando and Oteo-Iglesias, Jesús and Ruiz-Garbajosa, Patricia and Cantón, Rafael and Valcárcel-Fraile, Nuria and Gallego, Lucía and Roiz-Mesones, María Pía and Calvo-Montes, Jorge and Martínez-Martínez, Luis and Ocampo-Sosa, Alain and García-Fernández, Sergio and GEMARA-GESPABE Study Group, GEMARA-GESPABE Study Group},
title = {Evaluation of carbapenem inactivation method-based phenotypic assays for the detection of GES-type carbapenemases in Enterobacterales, Pseudomonas aeruginosa , and Acinetobacter baumannii},
journal = {Journal of Clinical Microbiology},
year = {2026},
volume = {64},
number = {9},
doi = {10.1128/jcm.00737-26}
}
EUVIMED